Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
Elizabeth M. Rhea, Aric F. Logsdon, Kim M. Hansen, et al.
Nature Neuroscience (2020) Vol. 24, Iss. 3, pp. 368-378
Open Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Maxime Taquet, John Geddes, Masud Husain, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 5, pp. 416-427
Open Access | Times Cited: 1938
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
Bruno Andrade, Sérgio Siqueira, Wagner Rodrigues de Assis Soares, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 700-700
Open Access | Times Cited: 400
Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses
Woo‐Jung Song, Christopher Hui, James H. Hull, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 5, pp. 533-544
Open Access | Times Cited: 313
How COVID-19 shaped mental health: from infection to pandemic effects
Brenda W.J.H. Penninx, Michael E. Benros, Robyn S. Klein, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2027-2037
Open Access | Times Cited: 307
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 301
SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
Ling Zhang, Li Zhou, Linlin Bao, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 248
Understanding COVID-19-associated coagulopathy
Edward M. Conway, Nigel Mackman, Ronald Q. Warren, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 639-649
Open Access | Times Cited: 248
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 542-554
Open Access | Times Cited: 198
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 2, pp. 307-320
Open Access | Times Cited: 198
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
Lize M. Grobbelaar, Chantelle Venter, Maré Vlok, et al.
Bioscience Reports (2021) Vol. 41, Iss. 8
Open Access | Times Cited: 156
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113008-113008
Open Access | Times Cited: 150
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Erin F. Balcom, Avindra Nath, Christopher Power
Brain (2021) Vol. 144, Iss. 12, pp. 3576-3588
Open Access | Times Cited: 141
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
Zhonglei Wang, Liyan Yang
Journal of Ethnopharmacology (2021) Vol. 270, pp. 113869-113869
Open Access | Times Cited: 136
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2681-2681
Open Access | Times Cited: 134
Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
Li Yin Tan, Thamil Vaani Komarasamy, Vinod Balasubramaniam
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 133
SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties
Matthew G. Frank, Kathy Nguyen, Jayson B. Ball, et al.
Brain Behavior and Immunity (2021) Vol. 100, pp. 267-277
Open Access | Times Cited: 132
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 127
The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models
Rafał Butowt, Nicolas Meunier, Bertrand Bryche, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 6, pp. 809-822
Open Access | Times Cited: 118
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112189-112189
Open Access | Times Cited: 105
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
Frauke Seehusen, Jordan J. Clark, Parul Sharma, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 95
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis
Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 94
Neuroinflammation and COVID-19
Abigail Vanderheiden, Robyn S. Klein
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102608-102608
Open Access | Times Cited: 81
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Natalia M. Lyra e Silva, Fernanda G. Q. Barros‐Aragão, Fernanda G. De Felice, et al.
Neuropharmacology (2022) Vol. 209, pp. 109023-109023
Open Access | Times Cited: 76
Long COVID and neuropsychiatric manifestations (Review)
Vasiliki Efstathiou, Maria‐Ioanna Stefanou, Marina Demetriou, et al.
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top